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A major obstacle limiting the success of vascular conduit
placement remains the limited ability to obtain endothelial cover-
age of the graft luminal surface. Among the beneficial functions of
a confluent endothelium are thromboresistance, selective perme-
ability, and interactions with circulating blood elements and un-
derlying smooth muscle.
Clinical and laboratory results show that large-diameter high-
flow systems tolerate the use of conduits that lack an endothelial
lining. That is not the case for small caliber systems and systems
that have slower flow.
Conduits with slow blood flow and smaller-caliber conduits
perform poorly due to thrombotic complications, possibly due to
the lack of nitric oxide and prostacyclin and the longer interaction
of the blood elements with the nonendothelialized luminal surface.
This study and others like it focus on defining methods for
creating a conduit that has a confluent luminal endothelial lining
that tolerates placement in the circulation.
The scaffold, matrix or material of the graft, and the source
and conditions under which the endothelial cells are harvested and
placed on the conduit are important in determining the degree of
success in achieving endothelial confluence and the durability of
the endothelial layer when challenged with flow conditions. The
authors have demonstrated clearly that, in the short term, themore
complex culture conditions of cyclic shear stress produce an endo-
thelial graft lining that functions in a manner superior to that
produced by conditions of steady shear stress at low or high levels.noted in terms of maintenance of integrity of the endothelial layer
and inhibition of adhesion of circulating blood elements to the
luminal surface of the graft.
The authors observed by Western blotting increased expres-
sion of endothelial nitric oxide synthase and prostaglandin I syn-
thase in the cyclic shear stress conduits compared with the conduits
created under other conditions. Defining the role of these or other
biologic molecules in conferring favorable graft function will re-
quire formal investigation. The functional performance character-
istics of the endothelial lining of a conduit likely are the result of
many factors, one of which appears to be the type of shear stress
used when creating the endothelial monolayer. Other factors may
include the scaffold, the origin of the endothelial cells and their
culture conditions, both biologic and mechanical.
The ideal conduit for certain applications may also include
smoothmuscle cells along with endothelial cells to allow for amore
durable structure or potentially for biologic molecule delivery via
vascularized structures that have genetically engineered cells de-
signed to deliver physiologic regulatory molecules locally or to the
circulation. Patterns of molecular expression that may be expected
to yield favorable endothelial performance characteristics might
possibly include robust eNOS expression and decreased expression
of tissue factor and other unfavorable candidate molecules.
Additional work, including longer-term studies and studies in
arterial-arterial grafts is required to adequately address the chal-
lenge of adequate conduit design.
